|
Volumn 30, Issue 4, 2001, Pages 407-409
|
Amplification of AMLI in childhood acute lymphoblastic leukemias
a,b a,b,c a a d d d a,b |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ASPARAGINASE;
CYTARABINE;
DOXORUBICIN;
GENE PRODUCT;
METHOTREXATE;
PREDNISONE;
VINCRISTINE;
DNA BINDING PROTEIN;
ONCOPROTEIN;
RUNX1 PROTEIN, HUMAN;
TRANSCRIPTION FACTOR;
TRANSCRIPTION FACTOR RUNX1;
TUMOR PROTEIN;
ACUTE LYMPHOBLASTIC LEUKEMIA;
ARTICLE;
CANCER COMBINATION CHEMOTHERAPY;
CASE REPORT;
CHILD;
CHILDHOOD LEUKEMIA;
CLINICAL FEATURE;
FEMALE;
FLUORESCENCE IN SITU HYBRIDIZATION;
GENE AMPLIFICATION;
GENE CONTROL;
GENE MUTATION;
HUMAN;
HUMAN CELL;
LEUKEMOGENESIS;
MALE;
OUTCOMES RESEARCH;
PRIORITY JOURNAL;
SCHOOL CHILD;
ACUTE LYMPHOCYTIC LEUKEMIA;
CHROMOSOME BANDING PATTERN;
GENETICS;
CHILD;
CHROMOSOME BANDING;
CORE BINDING FACTOR ALPHA 2 SUBUNIT;
DNA-BINDING PROTEINS;
FEMALE;
GENE AMPLIFICATION;
HUMANS;
IN SITU HYBRIDIZATION, FLUORESCENCE;
LEUKEMIA, LYMPHOCYTIC, ACUTE, L1;
MALE;
NEOPLASM PROTEINS;
PROTO-ONCOGENE PROTEINS;
TRANSCRIPTION FACTORS;
|
EID: 0034745477
PISSN: 10452257
EISSN: None
Source Type: Journal
DOI: 10.1002/1098-2264(2001)9999:9999<::AID-GCC1107>3.0.CO;2-C Document Type: Article |
Times cited : (49)
|
References (17)
|